Introduction
============

Most common diseases result from the combined effect of genes and environmental factors and the interactions between them. Epigenetic effects and non-coding gene products have gained research focus over the last two decades because protein-coding genes cannot account for all observed genomic effects. Here we focus on microRNAs (miRNAs) as key regulators of health and disease. miRNAs are endogenous, single-stranded, short non-coding RNA sequences (\~ 22 nucleotides) that regulate gene expression at the posttranscriptional level. Since the first discovery of miRNAs in *Caenorhabditis elegans* ([@r77]), hundreds of miRNAs in eukaryotes have been identified to influence physiological processes such as development, growth, differentiation, immune reaction, and adaptation to stress ([@r149]; [@r169]). Diverse disease states, such as cancer and heart failure, are associated with distinct miRNA signatures, suggesting that specific miRNA programs are activated in pathophysiological processes ([@r14]).

Recent advances in molecular biology opened the opportunity for new approaches in population-based studies, in which exposures to a broad spectrum of environmental pollutants are evaluated in concert with biological systems, a concept proposed as the "exposome" ([@r163]). From this viewpoint, miRNAs could potentially be novel biomarkers of exposure. For the purpose of this review, we focused on the response of miRNAs to environmental exposures.

*miRNA characteristics*. miRNA-mediated gene silencing is accomplished by base pairing of the 5´ region of miRNAs with the target mRNA sequence, leading to translational repression and/or mRNA degradation ([@r1]). miRNAs have been paradoxically shown to up-regulate gene expression by enhancing translation under specific conditions ([@r150]). The effect of miRNA expression on gene expression is not linear, as multiple miRNAs may target the same mRNA, and the majority of mRNAs contain multiple binding sites for miRNAs, generating a highly complex regulatory network system ([@r125]). For details on miRNA synthesis, biogenesis, miRNA mechanism of action, see [Figure 1](#f1){ref-type="fig"} and reviews by [@r31] and [@r99].

![Overview of miRNA biogenesis. The canonical maturation of a miRNA includes the production of the primary miRNA transcript (pri-miRNA) by RNA polymerase II or III (Pol II/III) and cleavage of the pri-miRNA by the microprocessor complex Drosha--DGCR8 (Pasha) in the nucleus. The resulting precursor hairpin, the pre-miRNA, is exported from the nucleus by Exportin-5--Ran-GTP. In the cytoplasm, the RNase Dicer in complex with the double-stranded RNA-binding protein TRBP cleaves the pre-miRNA hairpin to its mature length. The functional strand of the mature miRNA is loaded together with Argonaute (Ago2) proteins into the RNA-induced silencing complex (RISC), where it guides RISC to silence target mRNAs through mRNA cleavage, translational repression, or deadenylation, whereas the passenger strand (black) is degraded.](ehp.1408459.g001){#f1}

*miRNA nomenclature*. miRNAs are named using the "miR" prefix and a unique identifying number (e.g., miR-1, miR-2). The identifying numbers are assigned sequentially, with identical miRNAs having the same number, regardless of organism. Paralogous sequences whose mature miRNAs differ at only one or two positions are given lettered suffixes: for example, miR-10a and miR-10b. Distinct hairpin loci that give rise to identical mature miRNAs have numbered suffixes (e.g., mir-281-1, mir-281-2). The mature sequences are designated "miR," whereas the precursor hairpins are labeled "mir." The -3p and -5p suffixes that sometimes appear within an miR name refer to the arm from which the mature sequence comes. For nomenclature guidelines, see [@r2].

*miRNA analysis techniques suitable for large epidemiological studies*. In recent years, miRNA expression changes following exposure to environmental toxicants, even before disease onset, have gained researchers' interest. The measure of miRNAs in large epidemiological studies needs to be high throughput and sensitive enough to detect small changes in healthy subjects. At the same time, techniques need to be affordable in order to be conducted in large population studies. Moreover, given the complexity of phenomena induced by exposure but not fully explained by an effect on a single transcript, current research is going toward genome-wide techniques. Another challenge is tissue specificity of miRNAs: The availability of only noninvasive samples in epidemiological studies conducted on healthy populations limits our capability to investigate target tissues and opens important questions on the meaning of those markers in surrogate tissues. In epidemiological research, free and exosomal miRNAs in body fluids are interesting study objects because of their potential to serve as a proxy for tissue-specific miRNAs. A limitation of this approach is that these miRNAs differ between different body fluids, and their function is not clear. Although miRNAs hold promise as exposure biomarkers, recent studies have been primarily disease focused \[reviewed by [@r34]\].

Genome-wide miRNA analysis can be achieved by amplification-based \[real-time quantitative reverse-transcriptase polymerase chain reaction (qRT-PCR)\], hybridization-based (microarrays), and sequencing-based \[next-generation sequencing (NGS)\] technologies. Method selection depends on the type of sample to be analyzed and the RNA preparation protocol used. qRT-PCR is considered the gold standard because of its sensitivity, specificity, accuracy, and simple protocols. qRT-PCR can evaluate candidate miRNA expression or array plates that include a large number of miRNAs in one reaction, to OpenArray® (Applied Biosystems, Life Technologies), which allows the simultaneous amplification of a very large panel of miRNAs using nanoscale volumes. In a recent review, [@r115] compared qRT-PCR to different array-based platforms used to study mRNAs/miRNAs.

Several miRNA microarray chip platforms that are commercially available \[e.g., Affymetrix GeneChip® 3.0 miRNA array (Affymetrix Inc.), Agilent Human miRNA Microarray system (Agilent Technologies), Exiqon miRCURY LNA™ microarray (Exiqon Inc.)\] differ in probe design and detection stringency. The limitation of this microarray chip method is the availability and stringency of probes on the chip platform that pair with miRNAs of interest. Microarrays have the advantage of being easily correlated to mRNA expression data, thus providing functional information. Furthermore, unlike other current miRNA analysis techniques, microarrays allow fast analysis of miRNAs without an arbitrary preselection step. However, the large amount of data produced can generate false-positive results, and the time-consuming step of validation by qRT-PCR is almost necessary.

NGS strategies based on deep sequencing overcome some of the technical drawbacks of probe-based methodologies, especially the ability to detect only previously known sequences ([@r129]). As miRNAs are sequenced directly, information about sequence variations or posttranscriptional RNA editing becomes available for further analysis. The newly developed Nanostring nCounter 27 (Nanostring Technologies Inc.) uses two sequence-specific capture probes to allow for discrimination between similar variants of a single miRNA. NGS technologies \[e.g., Illumina/Solexa (Illumina Inc.), GA Roche/454 GS FLX Titanium (Roche Diagnostics Corp.), and ABI/SOLID (Applied Biosystems)\] allow complete "miRnomes" to be sequenced and allow for the discovery of novel miRNAs and isoforms. Another benefit of NGS technology is that it can identify precursor and primary miRNAs as well as their mature forms. NGS will likely become the gold standard for miRNA analysis because of its ability to sequence short fragments in a high-throughput mode. The choice between these methods is a key factor in establishing the possibility of success of any epidemiological study. Each method has pros and cons and should be evaluated based on the specific research.

Methods
=======

*Search strategy and selection criteria*. To identify the articles relevant to this topic, we undertook a comprehensive search of the PubMed (<http://www.ncbi.nlm.nih.gov/pubmed>) and ScienceDirect (<http://www.sciencedirect.com/>) databases initially using "microRNA" and "environmental exposure" as key terms. We did additional searches in which we replaced "microRNA" with "mir," "miRNA," or "epigenetic changes" and we substituted "environmental exposure" with "smoking," "passive smoking," "cigarette smoke," "air pollution," "nanoparticle exposure," "bisphenol A," "endocrine disruptors," or "chemical exposure" in every possible combination. We also considered review articles as well as references found in our literature search. We excluded articles not written in English. The PubMed search covered 1 January 1980 to 1 June 2014. Articles dealing only with the description of single nucleotide polymorphisms (SNPs) in miRNA genes were disregarded, as were those articles dealing only with the description of miRNAs in nonmammalian species. A flowchart detailing the search strategy is presented in [Figure 2](#f2){ref-type="fig"}. For miRNAs differentially expressed in response to more than one personal or environmental exposure, we researched disease phenotypes correlated with them by searching each of these miRNAs on the Human microRNA Disease Database (HMDD; <http://202.38.126.151/hmdd/mirna/md/>) and the miR2Disease Base (<http://www.mir2disease.org/>). Results of these searches are presented in [Table 1](#t1){ref-type="table"}, including the direction of regulation (up or down) of the miRNA and the ensuing phenotype.

![Flowchart of included studies.](ehp.1408459.g002){#f2}

###### 

miRNAs that are responsive to personal or environmental exposure and their roles in human disease.

  miRNA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Regulated                    Exposure                                                                                                          Diseases                                                                                                     Sources
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ---------------------------- ----------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------ -----------------------------------------------------------------------------------------------------------
  Let-7e                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Down                         TCDD                                                                                                              HCC, lung, pituitary, and breast cancer, GEP tumors                                                          Feitelson and Lee 2007; Qian et al. 2009; Rahman et al. 2009; Sakurai et al. 2012; Takamizawa et al. 2004
  Up                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 RDX                          Heart failure, asthma                                                                                             Polikepahad et al. 2010; Thum et al. 2007                                                                    
  Let-7g                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Down                         BPA, PM                                                                                                           Lung carcinoma, GEP tumors, breast cancer                                                                    Rahman et al. 2009; Sakurai et al. 2012
  miR-9                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Down                         PM                                                                                                                Brain cancer, Huntingon's disease                                                                            Ferretti et al. 2009; Lau and de Strooper 2010
  Up                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Aluminum                     Hodgkin lymphoma, breast cancer                                                                                   Leucci et al. 2012; Ma et al. 2010                                                                           
  miR-10b                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Down                         Formaldehyde, PM                                                                                                  Gastric cancer                                                                                               Kim K et al. 2011
  miR-21                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Down                         Smoking                                                                                                           Diabetes type 2                                                                                              Zampetaki et al. 2010
  Up                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 DEP, metal-rich PM           Breast cancer, glioblastoma, neo-intimal lesions, cardiac hypertrophy, atherosclerosis                            Ji et al 2007; Raitoharju et al. 2011; van Rooij et al. 2007; Volinia et al. 2006                            
  miR-26b                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Down                         DEP, BPA, PFOA                                                                                                    Schizophrenia, CRC, breast cancer                                                                            Earle et al. 2010; Liu et al. 2011; Perkins et al. 2007
  miR-31                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Down                         DEP, TCDD                                                                                                         Medulloblastoma, T-cell leukemia                                                                             Ferretti et al. 2009; Yamagishi et al. 2012
  miR-34b                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Down                         Smoking (2×)                                                                                                      CRC, pancreatic, mammary, ovarian, and renal cell carcinoma                                                  Vogt et al. 2011
  miR-92b                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Down                         Smoking, DDT                                                                                                      Medulloblastoma                                                                                              Genovesi et al. 2011
  miR-122                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Down                         Smoking                                                                                                           HCC                                                                                                          Bai et al. 2009
  Up                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 TCDD                         Hepatitis C, renal cell carcinoma, male infertility, sepsis, hyperlipidemia                                       Gao et al. 2012; Henke et al. 2008; Wang C et al. 2011; Wang H et al. 2012; White et al. 2011                
  miR-125b                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Down                         Smoking (2×)                                                                                                      Breast cancer, head and neck cancer                                                                          Nakanishi et al. 2014; Zhang et al. 2011
  Up                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Aluminum sulfate (2×)        Endometriosis, cardiac hypertrophy, Alzheimer's disease                                                           Busk and Cirera 2010; Lukiw and Alexandrov 2012; Ohlsson Teague et al. 2009                                  
  miR-135b                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Down                         DEP                                                                                                               Medulloblastoma                                                                                              Lv et al. 2012
  Up                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Smoking                      CRC                                                                                                               Nagel et al. 2008                                                                                            
  miR-142                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Down                         Formaldehyde                                                                                                      Heart failure                                                                                                Voellenkle et al. 2010
  Up                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Smoking                      B-cell ALL                                                                                                        Ju et al. 2009                                                                                               
  miR-143                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Up                           PM, ozone                                                                                                         Colon cancer                                                                                                 Zhang et al. 2013
  miR-146a                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Down                         Smoking                                                                                                           Postpartum psychosis, type 2 diabetes                                                                        Weigelt et al. 2013; Zampetaki et al. 2010
  Up                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 BPA, aluminum sulfate (2×)   Alzheimer's disease, Creutzfeldt-Jakob disease, atherosclerosis, leukemia, protection against myocardial injury   Lukiw and Alexandrov 2012; Lukiw et al. 2011; Raitoharju et al. 2011; Wang et al. 2013; Wang Y et al. 2010   
  miR-149                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Up                           BPA, DDT                                                                                                          Melanoma                                                                                                     Jin et al. 2011
  miR-155                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Down                         PM                                                                                                                Hypertension                                                                                                 Xu et al. 2008
  Up                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 PM                           Breast cancer, Hodgkin lymphoma, B-ALL                                                                            Chang et al. 2011; Kong et al. 2014; Palma et al. 2014                                                       
  miR-181a                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Down                         Formaldehyde                                                                                                      Leukemia, glioma, NSCLC, breast cancer, metabolic syndrome, and CAD                                          Gao et al. 2010; Hulsmans et al. 2012; Marcucci et al. 2008; Ota et al. 2011; Shi et al. 2008
  Up                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 TCDD                         Severe preeclampsia, male infertility                                                                             Hu et al. 2009; Wang C et al. 2011                                                                           
  miR-203                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Down                         Smoking, formaldehyde                                                                                             Myeloma                                                                                                      Wong et al. 2011
  miR-205                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Up                           Smoking (2×)                                                                                                      Heart failure, lung cancer                                                                                   Thum et al 2007; Yanaihara et al. 2006
  miR-206                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Up                           Smoking, RDX                                                                                                      Myocardial infarct, slows ALS progression, myotonic dystrophy                                                Gambardella et al. 2010; Shan et al. 2009; Williams et al. 2009
  miR-222                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Up                           Metal-rich PM, BPA                                                                                                Severe preeclampsia, thyroid carcinoma, prostate cancer, breast cancer                                       Hu et al. 2009; Miller et al. 2008; Pallante et al. 2006
  miR-223                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Down                         Smoking                                                                                                           AML                                                                                                          Eyholzer et al. 2010
  Up                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Smoking                      Heart failure, atherosclerosis                                                                                    Greco et al. 2012; Kin et al. 2012                                                                           
  miR-338-5p                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Down                         Formaldehyde                                                                                                      Melanoma                                                                                                     Caramuta et al. 2010
  Up                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 DEP                          Oral carcinoma                                                                                                    Scapoli et al. 2010                                                                                          
  miR-340                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Down                         Smoking                                                                                                           NA                                                                                                           NA
  Up                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Smoking                      Heart failure, breast cancer                                                                                      Thum et al. 2007; Wu et al. 2011                                                                             
  miR-638                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Up                           BPA, DDT, arsenic                                                                                                 Lupus nephritis                                                                                              Dai et al. 2009
  miR-663                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Up                           BPA, DDT, arsenic                                                                                                 CTCL, nasopharyngeal carcinoma, burns                                                                        Liang et al. 2012; Ralfkiaer et al. 2011; Yi et al. 2012
  Abbreviations: ACC, acute lymphocytic leukemia; ALS, amyotrophic lateral sclerosis; AML, acute myeloid leukemia; B-ALL, B-cell acute lymphocytic leukemia; BPA, bisphenol A; CAD, coronary artery disease; CRC, colorectal carcinoma; CTCL, cutaneous T-cell lymphoma; DDT, dichlorodiphenyltrichloroethane; DEP, diesel exhaust particles; GEP, gastroenteropancreatic; HCC, hepatocellular carcinoma; NA, not applicable; NSCLC, non-small cell lung carcinoma; PFOA, perfluorooctanoic acid; PM, particulate matter; RDX, hexahydro-1,3,5-trinitro-*s*-triazine; TCDD, 2,3,7,8-tetrachlorodibenzo-*p*-dioxin.                                                                                                                                                                                                                                                               

Results
=======

*Smoking-induced changes in miRNA expression*. The most studied environmental factor in relation to epigenetics is smoking; it was among the first factors shown to affect the miRNA machinery in humans ([@r136]). Results of *in vitro* studies concerning smoking and miRNAs are summarized in [Table 2](#t2){ref-type="table"}.

###### 

*In vitro* studies on the effects of smoking on differential miRNA expression.

  miRNA      miR function                      Regulation   Tissue/cell type                     Source
  ---------- --------------------------------- ------------ ------------------------------------ ----------------------
  miR-15a    Tumor suppressor                  Down         Primary bronchial epithelial cells   Schembri et al. 2009
  miR-125b   Targets *p53*, stress response                                                      
  miR‑199b   Oncogene activation                                                                 
  miR-218    Tumor suppressor                                                                    
  miR-31     Apoptosis, tumor suppressor       Up           Normal and cancer lung cells         Xi et al. 2010
  miR-21     Fatty acid synthesis, apoptosis   Up           Human squamous carcinoma cells       Zhang et al. 2014
  miR-452    Targets *CDK1*                    Down         Human alveolar macrophages           Graff et al. 2012

[@r60] analyzed miRNA expression patterns in the lungs of mice exposed to passive cigarette smoke, and they established life-course--related miRNA expression changes by comparing miRNA expression in lungs from unexposed newborn, postweaning, and adult mice. These researchers observed developmental-stage--specific miRNA expression profiles in which miRNAs that were highly expressed in newborns tended to be less expressed in adult mice and vice versa, whereas miRNA expression in postweaning mice was intermediate ([@r60]). Results from *in vivo* studies concerning smoking and miRNAs are shown in [Table 3](#t3){ref-type="table"}.

###### 

*In vivo* studies on the effects of smoking on differential miRNA expression.

  miRNA                                                                                                                     miR function                                       Regulation   Tissue/cell type        Source
  ------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------- ------------ ----------------------- --------------------------
  miR-34b                                                                                                                   p53 effector                                       Down         Mouse lung              Izzotti et al. 2011
  miR-421                                                                                                                   Targets *SMAD4*, polycomb gene *CBX7, ATM*                                              
  miR-450b                                                                                                                  No validated targets                                                                    
  miR-466                                                                                                                   No validated targets                                                                    
  miR-469                                                                                                                   Mouse miR not validated                                                                 
  miR-135b                                                                                                                  Inflammation, oxidative stress                     Up           Mouse lung              Halappanavar et al. 2013
  miR-206                                                                                                                   Targets *SERP1, BDNF, FOXP1*                       Up           Rat serum               Wu et al. 2013
  miR-133b                                                                                                                  Targets *LAG1, PTBP2*                                                                   
  miR-20b                                                                                                                   Hypoxia                                            Down         Mouse lung and plasma   Huang et al. 2012
  miR-30e                                                                                                                   Targets *UBC9, UBE21, MUC17*                                                            
  miR-125b                                                                                                                  Targets *p53*, stress response                                                          
  miR-128                                                                                                                   Apoptosis                                                                               
  let-7a                                                                                                                    Cell proliferation, angiogenesis                   Down         Mouse lung              Izzotti et al. 2009
  let-7b                                                                                                                    Cell proliferation, angiogenesis                                                        
  let-7f                                                                                                                    Cell proliferation, angiogenesis                                                        
  miR-26a                                                                                                                   Transforming growth factor expression                                                   
  miR-30b                                                                                                                   Cell adhesion, stress response                                                          
  miR-30c                                                                                                                   Cell cycle, oncogene activation                                                         
  miR-34b                                                                                                                   p53 effector                                                                            
  miR-99b                                                                                                                   Apoptosis                                                                               
  miR-122a                                                                                                                  Stress response                                                                         
  miR-124a                                                                                                                  Stress response, cell growth and differentiation                                        
  miR-125a                                                                                                                  Oncogene activation, ROS                                                                
  miR-125b                                                                                                                  Targets *p53*, stress response                                                          
  miR-140                                                                                                                   p53 effector                                                                            
  miR-192                                                                                                                   Oncogene activation                                                                     
  miR-431                                                                                                                   Protein repair, oncogene activation                                                     
  miR-92b                                                                                                                   Tumor suppressomiR                                 Down         Mouse serum             Yuchuan et al. 2014
  miR-668                                                                                                                   Inflammation                                                                            
  miR-700                                                                                                                   Inflammation                                                                            
  Let-7e                                                                                                                    Apoptosis                                          Up           Mouse serum             Yuchuan et al. 2014
  miR-19a                                                                                                                   OncomiR                                                                                 
  miR-142                                                                                                                   Immunology                                                                              
  miR-191                                                                                                                   OncomiR                                                                                 
  miR-350                                                                                                                   Unknown                                                                                 
  Abbreviations: oncomiR, miR with oncogenic properties; ROS, reactive oxygen species; suppressomiR, tumor suppresor miR.                                                                                           

Two studies reported a comparison between mRNA and miRNA whole genome expression patterns for smokers and nonsmokers ([@r128]; [@r141]). [@r141] reported that quitting smoking altered the plasma miRNA profiles to resemble those of nonsmokers. In addition, Let-7c and miR-150 could be of importance in the initiation of smoke-induced decline of lung function, because genes that were associated with lung function impairment in genome-wide association studies have been reported to be significantly enriched in binding sites for these miRNAs, namely *STAT3* ([@r117]) and *TNFR-II* ([@r30]).

The effect of *in utero* exposures on health during childhood and later in life is a growing area of research interest with major public health implications ([@r48]). An adaptive response in the fetus to *in utero* exposures can result in persistent changes into adulthood. miRNA expression levels in placenta can affect health later in life ([@r92]). Studies on miRNA expression and human exposure at different stages of life (*in utero*, adult) are included in [Table 4](#t4){ref-type="table"}.

###### 

Human studies on the effects of exposure to smoking on differential miRNA expression.

  miRNA                miR function                          Regulation   Tissue/cell type          Source
  -------------------- ------------------------------------- ------------ ------------------------- -----------------------------
  miR-16               p53, cell cycle, JAK/STAT signaling   Down         Placenta                  Maccani et al. 2010
  miR-21               Fatty acid synthesis, apoptosis                                              
  miR-146a             Inflammation, NFκβ mediator                                                  
  miR-223              Immunology                            Up           Maternal and cord blood   Herberth et al. 2013
  miR-129              Cell cycle regulation, apoptosis      Down         Spermatozoa               Marczylo et al. 2012
  miR-634              Inflammation                                                                 
  miR-340              Cell migration and invasion           Up           Spermatozoa               Marczylo et al. 2012
  miR-365              Targets *NKX2.1*                                                             
  miR-143              Cardiogenesis                         Down         Gastric tissue            Stánitz et al. 2013
  miR-21               Fatty acid biosynthesis, apoptosis    Up           Gastric tissue            Stánitz et al. 2013
  Let-7c               Cell proliferation, angiogenesis      Down         Induced sputum            Van Pottelberge et al. 2011
  miR-146a             Inflammation, NFκβ mediator                                                  
  miR-150              Hematopoeiesis                                                               
  miR-203              DNA damage response                                                          
  miR-340              Cell migration and invasion                                                  
  miR-443              Unknown                                                                      
  miR-223              Immunology                            Down         Plasma MV                 Badrnya et al. 2014
  miR-29b              Apoptosis                             Up           Plasma MV                 Badrnya et al. 2014
  RNU6-2               Reference miR                                                                
  MV, microvesicles.                                                                                

Not surprisingly, miRNAs that are frequently observed to be down-regulated in response to smoking have also been identified as down-regulated in lung ([@r143]), pancreatic ([@r152]), and stomach ([@r121]) cancer. Development of cardiovascular disease is associated with up-regulation of miR-206 ([@r131]), and this miRNA has significantly higher expression levels in smokers than in nonsmokers. Furthermore, two miRNAs that are frequently down-regulated in association with cigarette smoke (i.e., miR-21 and miR-146a) have lower expression levels in individuals with type 2 diabetes compared with healthy controls ([@r176]). Therefore, these miRNAs could support the observation that smoking is an independent risk factor for type 2 diabetes ([@r24]). Human studies concerning smoking-induced changes of miRNA expression are summarized in [Table 4](#t4){ref-type="table"}. [Figure 3](#f3){ref-type="fig"} is a Venn diagram displaying the common and distinct miRNAs from *in vitro*, *in vivo*, and human studies on smoking-induced miRNA alterations. miR-125b and miR-21, identified in *in vivo* and human studies, respectively, were also reported in *in vitro* studies. Furthermore, several miRNAs were identified in multiple studies, such as miR-34b and miR-146a.

![Venn diagram displaying common and distinct microRNAs associated with smoking in *in vitro*, *in vivo*, and human studies. miRNAs in bold type were identified in more than one study included in this meta-analysis.](ehp.1408459.g003){#f3}

[Table 1](#t1){ref-type="table"} summarizes miRNAs with altered expression in response to environmental and/or personal exposures reported in at least two independent studies, along with their known roles in disease etiology. miRNAs observed in association with either environmental or personal exposures are often associated with cancer; in particular, breast and lung cancer and leukemia have been frequently reported ([Table 1](#t1){ref-type="table"}). Furthermore, many aberrations in the cardiovascular system have been reported, such as hypertension, heart failure, myocardial infarct, and atherosclerosis. Exposures such as air pollution and smoking can cause cardiovascular disease and cancer ([@r113]); however, the data shown in [Table 1](#t1){ref-type="table"} indicate that the listed miRNAs play a causative role in disease etiology, rather than being merely a marker of exposure.

*Air pollution exposure and miRNA expression*. Particulate matter (PM) is a complex mixture of small particles and liquid droplets. Particle pollution is made up of a number of components, including acids, organic chemicals, metals, and soil or dust particles. The size of particles is directly linked to their potential to cause health problems ([@r12]). Although the clinical effects of PM exposure are obvious, the underlying mechanism of disease initiation and progression is less well understood. miRNAs play a pivotal role in maintaining healthy lungs ([@r103]). Because the lungs are an important target site for PM, we suggest that miRNAs could underlie the observed health effects of PM exposure. *In vitro* studies on air pollution and miRNAs are summarized in [Table 5](#t5){ref-type="table"}.

###### 

*In vitro* studies on air pollution--induced changes in miRNA expression.

  miRNA                                                                                                         miR function                     Regulation   Tissue/cell type                           Pollutant         Source
  ------------------------------------------------------------------------------------------------------------- -------------------------------- ------------ ------------------------------------------ ----------------- --------------------
  miR-26b                                                                                                       Wnt, p53, autophagy, TGF-β       Down         Primary human bronchial epithelial cells   10 μg/cm^2^ DEP   Jardim et al. 2009
  miR-27a                                                                                                       Apoptosis, ERα                                                                                             
  miR-31                                                                                                        Apoptosis, tumor supressor                                                                                 
  miR-96                                                                                                        Several unrelated targets                                                                                  
  miR-135b                                                                                                      Inflammation, oxidative stress                                                                             
  miR-374a                                                                                                      Targets *DICER*, *ATM*                                                                                     
  miR-513c                                                                                                      No validated targets             Up           Primary human bronchial epithelial cells   10 μg/cm^2^ DEP   Jardim et al. 2009
  miR-513b                                                                                                      No validated targets                                                                                       
  miR-513a-5p                                                                                                   Targets *CD274*, immunology                                                                                
  miR-923                                                                                                       Fragment of 28S RNA                                                                                        
  miR-494                                                                                                       Targets *PTEN*                                                                                             
  miR-338-5p                                                                                                    ABC transporters, endocytosis                                                                              
  miR-10b                                                                                                       Angiogenesis                     Down         Human A549 lung carcinoma cell line        1 ppm CH~2~O      Rager et al. 2011
  miR-181a                                                                                                      Apoptosis, oncomiR                                                                                         
  miR-330                                                                                                       Targets *E2F1, VEGFa, NTRK3*                                                                               
  miR-338-5p                                                                                                    ABC transporters, endocytosis                                                                              
  miR-375                                                                                                       Immunology                       Up           Human bronchial epithelial cells           3 μg/cm^2^ DEP    Bleck et al. 2013
  miR-149                                                                                                       Immunology                       Down         Monkey airway epithelial cells             Ozone             Clay et al. 2014
  miR-128                                                                                                       Apoptosis                        Up           Human A549 lung carcinoma cell line        PM~10~            Motta et al. 2013
  Abbreviations: CH~2~O, formaldehyde; DEP, diesel exhaust particles; OncomiR, miR with oncogenic properties.                                                                                                              

In a cohort study of steel plant workers, [@r10] examined the effect of PM exposure on miRNA expression. Blood samples were collected at the beginning of the working week ("preexposure") and at the end of the working week ("postexposure"). PM mass and metal components measured in the plant were correlated with miRNA expression analyses of blood samples. Urinary 8-hydroxy-2´-deoxyguanosine (8-OH-dG) levels were measured as a readout of oxidative stress. Both miR-222 and miR-21 were significantly increased in post- versus preexposure samples, and only miR-21 expression levels were positively correlated with 8-OH-dG ([@r10]). Oxidative stress has been reported to induce miR-21 expression ([@r21]); thus, the association between 8-OH-dG and miR-21 might simply reflect the response of miR-21 to production of reactive oxygen species (ROS) in the blood due to the PM-induced increase in oxidative stress ([@r10]) ([Table 6](#t6){ref-type="table"}).

###### 

Human studies on air pollution--induced changes in miRNA expression.

  miRNA                                                                                                                                                                    miR function                      Regulation   Tissue/cell type             Pollutant                                        Source
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------ --------------------------------- ------------ ---------------------------- ------------------------------------------------ ----------------------
  miR-21                                                                                                                                                                   Fatty acid synthesis, apoptosis   Up           Peripheral blood             300 μg PM~2.5~/m^3^ DEP                          Yamamoto et al. 2013
  miR-30e                                                                                                                                                                  Targets *UBC9, MUC17*                                                                                                        
  miR-144                                                                                                                                                                  Targets *Klfd, FGG, PLAG1*                                                                                                   
  miR-215                                                                                                                                                                  Cell cycle, *p53* activation                                                                                                 
  miR-21                                                                                                                                                                   Fatty acid synthesis, apoptosis   Up           Blood leukocytes             Metal-rich PM                                    Bollati et al. 2010
  miR-222                                                                                                                                                                  Cell cycle regulation                                                                                                        
  miR-375                                                                                                                                                                  Immunology                        Up           Bronchial epithelial cells   3 μg/cm^2^ DEP                                   Bleck et al. 2013
  miR-34a                                                                                                                                                                  Cardiogenesis                     Up           Gastric tissue               Urban living                                     Stánitz et al. 2013
  miR-143                                                                                                                                                                  Cardiogenesis                                                                                                                
  miR-10b                                                                                                                                                                  Angiogenesis                      Up           Spermatozoa                  Metal-rich PM                                    Li et al. 2012a
  miR-33b                                                                                                                                                                  Lipid metabolism                                                                                                             
  miR-106a                                                                                                                                                                 OncomiR                                                                                                                      
  miR-155                                                                                                                                                                  Inflammation                                                                                                                 
  miR-183                                                                                                                                                                  OncomiR                                                                                                                      
  miR-205                                                                                                                                                                  OncomiR                                                                                                                      
  miR‑208a                                                                                                                                                                 Cardiac hypertrophy                                                                                                          
  miR-222                                                                                                                                                                  Cell cycle regulation                                                                                                        
  miR-223                                                                                                                                                                  Immunology                                                                                                                   
  Let-7d                                                                                                                                                                   Proliferation, angiogenesis       Down         Spermatozoa                  Metal-rich PM                                    Li et al. 2012a
  miR-363                                                                                                                                                                  DNA damage response                                                                                                          
  miR-25                                                                                                                                                                   DNA damage response               Up           Induced sputum               Ozone                                            Fry et al. 2014
  miR-132                                                                                                                                                                  Angiogenesis                                                                                                                 
  miR-143                                                                                                                                                                  Cardiogenesis                                                                                                                
  miR-145                                                                                                                                                                  Tumor suppressor                                                                                                             
  miR-199a                                                                                                                                                                 Oncogene activation                                                                                                          
  miR-199b                                                                                                                                                                 Oncogene activation                                                                                                          
  miR-222                                                                                                                                                                  Cell cycle regulation                                                                                                        
  miR-223                                                                                                                                                                  Immunology                                                                                                                   
  miR-424                                                                                                                                                                  Angiogenesis                                                                                                                 
  miR-582                                                                                                                                                                  Antiapoptosis                                                                                                                
  miR-1                                                                                                                                                                    Apoptosis                         Down         Leukocytes                   PM~2.5~, black carbon, organic carbon, sulfate   Fossati et al. 2014
  miR-9                                                                                                                                                                    Neuronal differentiation                                                                                                     
  miR-21                                                                                                                                                                   Fatty acid synthesis, apoptosis                                                                                              
  miR-126                                                                                                                                                                  Angiogenesis                                                                                                                 
  miR-135a                                                                                                                                                                 Inflammation                                                                                                                 
  miR-146a                                                                                                                                                                 Inflammation, NFκβ mediator                                                                                                  
  miR-155                                                                                                                                                                  Inflammation                                                                                                                 
  miR-222                                                                                                                                                                  Cell cycle regulation                                                                                                        
  miR-128                                                                                                                                                                  Apoptosis                         Up           Plasma MV                    PM~10~                                           Motta et al. 2013
  Abbreviations: DEP, diesel exhaust particles; MV, microvesicles; OncomiR, miR with oncogenic properties; PM~2.5~, particulate matter ≤ 2.5 μm in aerodynamic diameter.                                                                                                                                

The cardiovascular anomalies observed in association with air pollution exposure have often been attributed to the generation of oxidative stress ([@r95]). MiR-21 is up-regulated in response to diesel exhaust particles and metal-rich PM ([@r10]; [@r11]) and is highly expressed in the cardiovascular system, where it plays an important role in vascular cell proliferation and apoptosis and disease \[reviewed by [@r22]\]. Therefore, miR-21 expression could be an important mechanistic link explaining the association between air pollution exposure and cardiovascular disease.

[@r79] observed distinct miRNA expression profiles in patients with asthma compared with controls after subway exposure. Current epidemiological studies have identified the first miRNAs associated with air pollution exposure, and provide a list of putative biomarkers. [Table 6](#t6){ref-type="table"} summarizes the human studies on air pollution and miRNAs. A Venn diagram displays the common and distinct miRNAs from *in vitro* and human studies on air pollution--induced miRNA alterations ([Figure 4](#f4){ref-type="fig"}). The only miRNAs identified in both *in vitro* and human studies in association with air pollution exposure are miR-10b and miR-128. Furthermore, miRNAs -9, -21, -143, -155, -222, -223, and -338 were identified in at least two independent studies on air pollution and miRNA.

![Venn diagram displaying common and distinct microRNAs associated with air pollution exposure in *in vitro* and human studies. miRNAs in bold type were identified in more than one study included in this meta-analysis.](ehp.1408459.g004){#f4}

*Nanoparticles*. Nanoparticles are emitted from natural and anthropogenic sources and are produced via nanotechnology. Fast propagation of nanotechnologies into different industries and consumer products is causing exponential growth of nanomaterial production. Hence, increasing amounts of nanoparticles reach occupational settings and the indoor and outdoor environments, thus representing a potentially serious hazard to human health ([@r17]; [@r104]). Nanoparticles are also able to cross cell membranes, and their interactions with biological systems are relatively unknown ([@r56]). [Table 7](#t7){ref-type="table"} includes the studies on nanoparticle-induced changes in miRNA expression, all of which were performed in animal models.

###### 

Studies on nanoparticle-induced changes in miRNA expression.

  miRNA                                                                       miR function                       Regulation   Pollutant                           Source
  --------------------------------------------------------------------------- ---------------------------------- ------------ ----------------------------------- ----------------------
  miR-21                                                                      Fatty acid synthesis, apoptosis    Up           0.268 or 0.162 mg carbon black NP   Bourdon et al. 2012
  miR-135b                                                                    Inflammation, oxidative stress                                                      
  miR-146                                                                     Inflammation, NFκβ mediator                                                         
  miR-122                                                                     Stress response                    Up           70 nm in silica NP                  Nagano et al. 2013
  miR-192                                                                     Oncogene activation                                                                 
  Let-7a                                                                      Cell proliferation, angiogenesis   Up           100 nm gold NP                      Balansky et al. 2013
  miR-183                                                                     OncomiR                                                                             
  Abbreviations: NP, nanoparticles; oncomiR, miR with oncogenic properties.                                                                                       

*Chemical exposure-induced changes in miRNA*. Formaldehyde. Formaldehyde is an air toxic present in the atmosphere due to emission from anthropogenic and biogenic sources. Ninety-five percent of inhaled formaldehyde is absorbed within the respiratory tract ([@r107]). Formaldehyde has been reported to change gene expression patterns in nasal and lung cells ([@r71]; [@r80]). The miRNAs reported to be down-regulated in association with formaldehyde exposure have been reported to be involved in the development of diverse tumors (e.g., breast and gastrointestinal cancer, melanoma) as well as heart failure ([Table 1](#t1){ref-type="table"}). Given the capability of formaldehyde to pass deep into lung tissue and enter systemic circulation, the link with cardiovascular disease and cancer has been widely discussed \[reviewed by [@r70]\]. Interestingly, miR-181a, one of the miRNAs down-regulated after formaldehyde exposure, was reported to affect the DNA damage response in breast cancer, enabling the identification of aggressive breast tumors based on increased miR-181a expression ([@r8]).

Endocrine disruptors. Organochlorine pesticides and plasticizing agents are ubiquitous environmental endocrine-disrupting compounds that impact human health ([@r124]). Bisphenol A (BPA) is an industrial plasticizer often used as a coating in food cans and in plastic bottles ([@r68]). Dichlorodiphenyltrichloroethane (DDT) is a well-known organochlorine pesticide. Because DDT is very persistent in the environment, accumulates in fatty tissues, and can travel long distances in the upper atmosphere, residues from historical use remain a current threat to human health.

DDT and BPA have been reported to interfere with endogenous estrogens and thyroid hormone, leading to aberrations of the reproductive, immune, and central nervous systems ([@r23]; [@r84]). DDT ([@r154]) and BPA ([@r142]) cross the placental barrier and can induce *in utero* effects that could lead to detrimental effects later in life.

[@r135] reported that prenatal exposure to BPA can alter mammary development and lead to breast cancer in humans. From a clinical perspective, it is interesting that decreased expression of *let-7f* has been associated with increased breast cancer risk ([@r126]), and treatment of MCF-7 breast cancer cells with BPA resulted in reduced *let-7f* expression ([@r145]). Furthermore, miR-146a has been proposed to induce an Alzheimer's disease pathway ([@r65]) and is up-regulated after BPA exposure ([Table 1](#t1){ref-type="table"}). Therefore, the neurodegenerative consequences of BPA exposure could at least partially be attributed to miR-146a. *In vitro* studies could provide researchers with interesting miRNAs that have potential to be used as biomarkers for chemical exposure.

Polychlorinated biphenyls (PCBs) were widely used organic chemicals until their production was banned because of environmental concerns ([@r114]). PCBs are stable compounds that bioaccumulate in fatty tissues ([@r138]); they have been reported to cause systemic changes in gene expression ([@r18]), suggesting that miRNA regulation could be involved in this process. [@r147] reported an association between maternal PCB exposure and fetal toxicity, impaired fetal growth, and pregnancy loss.

2,3,7,8-Tetrachlorodibenzo-*p*-dioxin (TCDD) has been reported to adversely affect the immune system in rats ([@r36]). In addition, [@r15] reported that TCDD exposure of pregnant mice affected the immune system of fetuses by suppressing T-cell function. Given the regulatory role miRNAs play in the immune system ([@r26]), it can be expected that miRNAs are important in regulating the detrimental health effects observed after exposure to TCDD and PCBs.

Arsenic. Environmental exposure to arsenic, especially to trivalent inorganic arsenic (As^3+^), is a health concern given the high concentrations present in groundwater across the world ([@r38]). Exposure to arsenic has been associated with increased risk of cancer due to genomic instability ([@r32]), and long-term arsenic exposure has been observed to induce peripheral vascular injury ([@r146]). A Venn diagram showing the common and distinct miRNAs from *in vitro* and human studies on arsenic-induced miRNA alterations is presented in [Figure 5](#f5){ref-type="fig"}. Only miRNA-21 was associated with arsenic exposure in *in vitro* model systems and in human studies. Three miRNAs were identified by at least two independent studies on arsenic exposure and miRNA expression, namely, miR-26b, miR-181a, and miR-222.

![Venn diagram displaying common and distinct microRNAs associated with arsenic exposure in *in vitro* and human studies. miRNAs in bold type were identified in more than one study included in this meta-analysis.](ehp.1408459.g005){#f5}

Aluminum sulfates. Aluminum is the most widely distributed metal in the environment and is extensively used in daily life. Chronic exposure of animals to aluminum is associated with behavioral and neuropathological changes ([@r42]). Epidemiological studies have shown poor performance in cognitive tests and a higher abundance of neurological symptoms in workers occupationally exposed to aluminum ([@r75]).

Hexahydro-1,3,5-trinitro-s-triazine (RDX). The polynitramine explosive RDX is a heavily used second-generation high explosive, and its use can result in the contamination of soils, sediments, and water ([@r28]). RDX exposure has been reported to be toxic to the neural and immune systems and to increase tumor incidence in several cancers ([@r46]; [@r140]).

Diethylstilbestrol (DES). The synthetic estrogen DES was prescribed to pregnant women from the 1940s to the 1960s in order to prevent miscarriages; however, DES was later reported to be responsible for increasing breast cancer in the mothers and gynecologic tumor incidence in their exposed daughters ([@r51]; [@r97]).

Perfluorooctanoic acid (PFOA). Perfluoroalkyl chemicals (PFCs) are highly stable and widely used in industrialized countries. PFCs are both lipophobic and hydrophobic; thus, after absorption they will bind to proteins in serum and liver rather than accumulate in lipids. PFOA is one of the most commonly used PFCs.

The studies we reviewed on chemical-induced changes in miRNA expression are summarized in [Tables 8](#t8){ref-type="table"}--[10](#t10){ref-type="table"} by type of study: *in vitro* ([Table 8](#t8){ref-type="table"}), *in vivo* ([Table 9](#t9){ref-type="table"}), and human ([Table 10](#t10){ref-type="table"}) studies.

###### 

*In vitro* studies on chemically induced changes in miRNA expression.

  miRNA                                                                                                                                                                                            miR function                         Regulation   Tissue/cell type                   Chemical   Source
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------ ------------ ---------------------------------- ---------- -----------------------------
  let-7g                                                                                                                                                                                           Cell proliferation, angiogenesis     Down         MCF-7 cells                        BPA        Tilghman et al. 2012
  let-7f                                                                                                                                                                                           Cell proliferation, angiogenesis                                                                
  miR-21                                                                                                                                                                                           Fatty acid biosynthesis, apoptosis                                                              
  miR-26b                                                                                                                                                                                          Wnt*,*p53*,* autophagy, TGF*-*β                                                                 
  miR-342-3p                                                                                                                                                                                       Tumor suppressomiR                                                                              
  miR-15b                                                                                                                                                                                          Tumor suppressor targeting *BCL2*    Down         MCF-7 cells                        BPA, DDT   Tilghman et al. 2012
  miR-222                                                                                                                                                                                          Cell cycle regulation                Up           MCF-7 cells                        BPA        Tilghman et al. 2012
  miR-638                                                                                                                                                                                          No known function                    Up           MCF-7 cells                        BPA, DDT   Tilghman et al. 2012
  miR-663                                                                                                                                                                                          Immunology, oxidative stress         Down         MCF-7 cells                        DDT        Tilghman et al. 2012
  miR-1915                                                                                                                                                                                         No known function                                                                               
  miR-27b                                                                                                                                                                                          Angiogenesis                                                                                    
  miR-92a                                                                                                                                                                                          Tumor supressomiR                                                                               
  miR-92b                                                                                                                                                                                          Tumor supressomiR                                                                               
  miR-1308                                                                                                                                                                                         No known function                    Up           MCF-7 cells                        DDT        Tilghman et al. 2012
  miR-146a                                                                                                                                                                                         Inflammation, NFκβ mediator          Up           Human placental cell lines         BPA        Avissar-Whiting et al. 2010
  miR-150                                                                                                                                                                                          Hematopoeiesis                       Down         Jurkat T cell line                 Arsenic    Sturchio et al. 2014
  miR-30d                                                                                                                                                                                          Autophagy                            Up           Jurkat T cell line                 Arsenic    Sturchio et al. 2014
  miR-142                                                                                                                                                                                          Immunology                                                                                      
  miR-181a                                                                                                                                                                                         Apoptosis, oncomiR                                                                              
  miR-221                                                                                                                                                                                          DNA damage response                                                                             
  miR-222                                                                                                                                                                                          Cell cycle regulation                                                                           
  miR-638                                                                                                                                                                                          No known function                                                                               
  miR-663                                                                                                                                                                                          Immunology, oxidative stress                                                                    
  miR-190                                                                                                                                                                                          OncomiR                              Up           Human bronchial epithelial cells   Arsenic    Beezhold et al. 2011
  miR-19b                                                                                                                                                                                          OncomiR                              Up           HUVEC cells                        Arsenic    Li et al. 2012b
  miR-21                                                                                                                                                                                           Fatty acid biosynthesis, apoptosis                                                              
  miR-24                                                                                                                                                                                           OncomiR                                                                                         
  miR-29b                                                                                                                                                                                          Apoptosis                                                                                       
  miR-33a                                                                                                                                                                                          Lipid metabolism                                                                                
  miR-198                                                                                                                                                                                          Cell proliferation                                                                              
  miR-508-5p                                                                                                                                                                                       Cell invasion and migration                                                                     
  miR-1252                                                                                                                                                                                         No known function                                                                               
  miR-181a                                                                                                                                                                                         Apoptosis, oncomiR                   Up           HepG2 cells                        PAH        Song et al. 2013
  miR-181b                                                                                                                                                                                         Apoptosis, oncomiR                                                                              
  miR-181d                                                                                                                                                                                         Apoptosis, oncomiR                                                                              
  Abbreviations: BPA, bisphenol A; DDT, dichlorodiphenyltrichloroethane; OncomiR, miR with oncogenic properties; PAH, polycyclic aromatic hydrocarbon; tumor suppressomiR, tumor suppressor miR.                                                                                                   

###### 

*In vivo* studies on chemically induced changes in miRNA expression.

  miRNA                                                                                                                                                                              miR function                            Regulation   Tissue/cell type          Chemical       Source
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------- ------------ ------------------------- -------------- --------------------
  let-7e                                                                                                                                                                             Apoptosis                               Down         Fetal mouse thymocytes    TCDD           Singh et al. 2012
  miR-18b                                                                                                                                                                            Apoptosis                                                                                     
  miR-23a                                                                                                                                                                            Apoptosis                                                                                     
  miR-23b                                                                                                                                                                            Apoptosis                                                                                     
  miR-27a                                                                                                                                                                            Apoptosis, ERα                                                                                
  miR-28                                                                                                                                                                             Apoptosis                                                                                     
  miR-29a                                                                                                                                                                            Apoptosis                                                                                     
  miR-31                                                                                                                                                                             Apoptosis, tumor supressomiR                                                                  
  miR-98                                                                                                                                                                             Apoptosis                                                                                     
  miR-101b                                                                                                                                                                           Apoptosis                                                                                     
  miR-181c                                                                                                                                                                           Apoptosis, oncomiR                                                                            
  miR-182                                                                                                                                                                            Apoptosis                                                                                     
  miR-200a                                                                                                                                                                           Apoptosis, cell cycle, MAPK                                                                   
  miR-23                                                                                                                                                                             Apoptosis                                                                                     
  miR-290                                                                                                                                                                            Apoptosis                                                                                     
  miR-335                                                                                                                                                                            Apoptosis                                                                                     
  miR-491                                                                                                                                                                            Apoptosis, targets *BCL-XL*                                                                   
  miR-122                                                                                                                                                                            Stress response                         Up           Fetal mouse thymocytes    TCDD           Singh et al. 2012
  miR-181a                                                                                                                                                                           OncomiR                                                                                       
  miR-125b                                                                                                                                                                           Targets *p53*, stress response          Up           Monkey nasal epithelium   Formaldehyde   Rager et al. 2013
  miR-152                                                                                                                                                                            Tumor suppressor, methylation                                                                 
  miR-219                                                                                                                                                                            NMDA receptor signaling                                                                       
  miR-532                                                                                                                                                                            Unknown                                                                                       
  miR-22                                                                                                                                                                             PTEN*,*AKT signaling                    Down         Monkey nasal epithelium   Formaldehyde   Rager et al. 2013
  miR-26b                                                                                                                                                                            Wnt, p53, autophagy, TGF-β                                                                    
  miR-29a                                                                                                                                                                            Apoptosis                                                                                     
  miR-140                                                                                                                                                                            p53 effector                                                                                  
  miR-142                                                                                                                                                                            Immunology                                                                                    
  miR-145                                                                                                                                                                            Tumor suppressor, stem cell different                                                         
  miR-203                                                                                                                                                                            DNA damage response                                                                           
  miR-374a                                                                                                                                                                           Targets *DICER, ATM*                                                                          
  miR-520f                                                                                                                                                                           Unknown                                                                                       
  miR-27a                                                                                                                                                                            Apoptosis, ERα                          Down         Mouse brain and liver     RDX            Zhang and Pan 2009
  miR-200c                                                                                                                                                                           Apoptosis                                                                                     
  let7-e                                                                                                                                                                             Apoptosis                                                                                     
  miR-206                                                                                                                                                                            Targets *SERP1, BDNF, FOXP1*                                                                  
  miR-451                                                                                                                                                                            Targets *PI3K*/*AKT*                    Down         Rat liver                 PFOS           Wang et al. 2014
  miR-23a                                                                                                                                                                            Apoptosis                               Up           Rat liver                 PFOS           Wang et al. 2014
  miR-25                                                                                                                                                                             DNA damage response                                                                           
  miR-125a                                                                                                                                                                           Oncogene activation, ROS                                                                      
  miR-133a                                                                                                                                                                           Smooth muscle differentiation                                                                 
  miR-133b                                                                                                                                                                           Targets *LAG1* and *PTBP2*                                                                    
  miR-206                                                                                                                                                                            Targets *SERP1, BDNF, FOXP1*                                                                  
  miR-494                                                                                                                                                                            Targets *PTEN*                                                                                
  miR-542                                                                                                                                                                            DNA damage response                                                                           
  Abbreviations: OncomiR, miR with oncogenic properties; PFOS, perfluorooctane sulfonate; RDX, hexahydro-1,3,5-trinitro-*s*-triazine; TCDD, 2,3,7,8-tetrachlorodibenzo-*p*-dioxin.                                                                                                 

###### 

Human studies on chemically induced changes in miRNA expression.

  miRNA                                                                                                                              miR function                         Regulation   Tissue/cell type    Chemical   Source
  ---------------------------------------------------------------------------------------------------------------------------------- ------------------------------------ ------------ ------------------- ---------- ----------------------
  miR-191                                                                                                                            OncomiR                              Up           Peripheral blood    PCB-169    Guida et al. 2013
  miR-146a                                                                                                                           Inflammation, NFκβ mediator          Up           Fetal brain cells   Aluminum   Pogue et al. 2009
  miR-9                                                                                                                              Neuronal differentiation                                                         
  miR-125b                                                                                                                           Targets *p53*, stress response       Up           Fetal brain cells   Aluminum   Lukiw and Pogue 2007
  miR-128                                                                                                                            Apoptosis                                                                        
  miR-199a                                                                                                                           Oncogene activation                  Up           Serum               PFOA       Wang J et al. 2012
  miR-21                                                                                                                             Fatty acid biosynthesis, apoptosis   Up           Blood samples       Arsenic    Kong et al. 2012
  miR-26b                                                                                                                            Wnt, p53, autophagy, TGF-β                                                       
  Let-7a                                                                                                                             Cell proliferation, angiogenesis     Up           Cord blood          Arsenic    Rager et al. 2014
  miR-16                                                                                                                             p53, cell cycle, JAK/STAT                                                        
  miR-17                                                                                                                             DNA damage response                                                              
  miR-20a                                                                                                                            Angiogenesis                                                                     
  miR-20b                                                                                                                            Hypoxia                                                                          
  miR-26b                                                                                                                            Wnt, p53, autophagy, TGF-β                                                       
  miR-96                                                                                                                             Several unrelated targets                                                        
  miR-98                                                                                                                             Apoptosis                                                                        
  miR-107                                                                                                                            Targets *Notch2*                                                                 
  miR-126                                                                                                                            Angiogenesis                                                                     
  miR-195                                                                                                                            Tumor suppressomiR                                                               
  miR-454                                                                                                                            Unknown                                                                          
  miR-24                                                                                                                             OncomiR                              Down         Plasma              PAH        Deng et al. 2014
  miR-27a                                                                                                                            Apoptosis, ERα                                                                   
  miR-28                                                                                                                             Apoptosis                                                                        
  miR-142                                                                                                                            Immunology                                                                       
  miR-150                                                                                                                            Hematopoeiesis                       Up           Plasma              PAH        Deng et al. 2014
  Abbreviations: OncomiR, miR with oncogenic properties; PAH, polycyclic aromatic hydrocarbon; suppressomiR, tumor suppressor miR.                                                                                    

Conclusions
===========

miRNAs are omnipresent in the genome and are important regulators of gene expression in response to intracellular as well as environmental cues. In this review, we examined the response of the miRNA machinery to personal and environmental exposures, including air pollution, cigarette smoking, and chemicals such as endocrine disruptors. miRNAs have been proposed as biomarkers for disease; however, the literature also reveals their potential to be used as biomarkers of environmental exposure.

In different studies on the same environmental pollutant, overall the identified miRNAs showed similar patterns of expression regulation. In studies where smoking-induced changes were investigated, the general observation was a down-regulation of expression. For example, miR-125b was down-regulated in response to cigarette smoke in both primary human bronchial epithelial cells ([@r128]) and mouse lung tissue ([@r60]). However, when unique miRNAs had altered expression patterns in response to different environmental exposures, their direction of regulation could be the same (10/25 miRNAs) or the opposite (15/25 miRNAs; 60%). The different exposures we discussed here have their own unique health effects, so one would not expect them to have the same effect on the miRNA machinery. However, there is sometimes a discrepancy when looking at the same exposure indicator; for example, in response to smoking, miR-21 has been reported to be up-regulated in some studies and down-regulated in others ([Table 4](#t4){ref-type="table"}). Part of the discrepancy can be explained by the different exposure models that were used.

In general, different *in vitro* studies show little overlap, potentially because of the complex miRNA--mRNA networks that underlie the observations and the differences in exposure used across studies. In studies of the same environmental pollutant *in vitro*, *in vivo*, or in humans, identified miRNAs were quite distinct ([Figures 3](#f3){ref-type="fig"}--[5](#f5){ref-type="fig"}). This can be explained in part by the observation that animal models do not always reflect genomic responses that occur in humans ([@r130]). Discrepancy between different studies might also stem from differences in exposure duration. For example, in a study in rats, the duration of exposure uniquely influenced expression patterns of the individual miRNAs ([@r61]).

Human epidemiological studies are necessary to observe exposure-related effects on miRNAs. Understanding the exposome requires putting together pieces of a complex puzzle. Epidemiological studies need input from experimental studies to identify good candidate biomarkers, and results from epidemiological studies often need follow-up by experimental studies to investigate mechanisms of action and to study tissue dependency of effects because human studies are most often performed in easily accessible tissues such as blood and saliva as a surrogate for the actual target tissues.

Currently, epidemiological studies on microRNA often involve free or exosomal miRNAs present in saliva or other body fluids. However, it is not clear whether these observed miRNA changes are a true reflection of the body's response and can really predict health effects. In blood, miRNAs within the exosomes have been shown to overlap with cellular miRNA profiles: [@r20] observed that exosomes derived from blood were enriched for miRNAs and that miRNA profiles between blood cells and the cell-free exosomal fraction showed important overlap.

Because miRNAs can regulate mRNA expression in both a negative manner and a positive manner ([@r150]) and because many miRNAs can bind the same mRNA ([@r125]), it is difficult to draw conclusions from miRNA studies without infomation on the concurrent mRNA(s) expression pattern. However, this information is rare in current reports on epidemiological studies of miRNAs. The findings of this review underscore the complex networks that are built by miRNAs and the mRNAs they regulate because one miRNA can influence many mRNAs according to the timing and pattern of expression.

Many of the reviewed studies used large-scale microarray profiling, but follow-up and validation with more quantitative approaches often lags behind. This delay is understandable because of the cost and labor intensity inherent to these techniques; however, it is important to confirm the miRNAs that are responsive to environmental exposures.

Researchers are currently publishing extensive lists of miRNAs that are responsive to environmental exposures and showing their utility as biomarkers of effect. Future research should focus on identifying the molecular mechanism behind miRNA expression changes in response to exposure to determine whether the changes in miRNA expression are merely a symptom of the (patho)physiological processes the organism undergoes after exposure, or whether miRNAs are the drivers responsible for these changes. [@r62] recently reviewed the putative mechanisms of action behind miRNAs' response to environmental exposure. However, the effect of the identified miRNAs on putative mRNA targets should also be studied to determine whether the change in miRNA expression has functional consequences and which mRNAs are true miRNA targets under the given circumstances.

At present, little is known about whether environmental exposures induce long-term changes in human miRNA expression or whether these have a transient character. To address this problem, more longitudinal studies should be conducted to examine the long-term effects of exposure. Results from animal studies suggest that miRNA expression changes in response to formaldehyde exposure are transient and revert to normal levels after recovery from exposure ([@r119]), but [@r61] reported that miRNA profiles in target organs did not recover 1 week after cessation of long-term cigarette smoke exposure. In a study in humans, [@r141] observed that miRNA expression profiles of individuals who quit smoking resembled those of nonsmokers.

Follow-up in future generations is necessary to determine the heritability of the miRNA expression changes. It would be very interesting to examine the effect of *in utero* environmental exposures on development of disease in later life and the role miRNAs play in inducing these health effects. Furthermore, long-term longitudinal studies would allow us to distinguish between cause and effect of miRNA expression and environmental exposure, and would also allow us to estimate the contribution of miRNAs to disease development. Studies have shown that miRNAs can be used as biomarkers of disease as well as biomarkers for environmental exposure and that miRNAs hold great potential to explain disease etiology.
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